Literature DB >> 18556141

Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study.

Marilyn Stovall1, Susan A Smith, Bryan M Langholz, John D Boice, Roy E Shore, Michael Andersson, Thomas A Buchholz, Marinela Capanu, Leslie Bernstein, Charles F Lynch, Kathleen E Malone, Hoda Anton-Culver, Robert W Haile, Barry S Rosenstein, Anne S Reiner, Duncan C Thomas, Jonine L Bernstein.   

Abstract

PURPOSE: To quantify the risk of second primary breast cancer in the contralateral breast (CB) after radiotherapy (RT) for first breast cancer. METHODS AND MATERIALS: The study population included participants in the Women's Environmental, Cancer, and Radiation Epidemiology study: 708 cases (women with asynchronous bilateral breast cancer) and 1399 controls (women with unilateral breast cancer) counter-matched on radiation treatment. Participants were <55 years of age at first breast cancer. Absorbed doses to quadrants of the CB were estimated. Rate ratios (RR) and 95% confidence intervals (CI) were calculated using multivariable-adjusted conditional logistic regression models.
RESULTS: Across all patients, the mean radiation dose to the specific quadrant of the CB tumor was 1.1 Gy. Women <40 years of age who received >1.0 Gy of absorbed dose to the specific quadrant of the CB had a 2.5-fold greater risk for CB cancer than unexposed women (RR = 2.5, 95% CI 1.4-4.5). No excess risk was observed in women >40 years of age. Women <40 years of age with follow-up periods >5 years had a RR of 3.0 (95% CI 1.1-8.1), and the dose response was significant (excess RR per Gy of 1.0, 95% CI 0.1-3.0).
CONCLUSIONS: Women <40 years of age who received a radiation dose >1.0 Gy to the CB had an elevated, long-term risk of developing a second primary CB cancer. The risk is inversely related to age at exposure and is dose dependent.

Entities:  

Mesh:

Year:  2008        PMID: 18556141      PMCID: PMC3782859          DOI: 10.1016/j.ijrobp.2008.02.040

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  29 in total

1.  Radiation therapy and the risk of contralateral breast cancer.

Authors:  Bruce G Haffty
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-07-15       Impact factor: 7.038

2.  Second malignancies after treatment of early-stage breast cancer: lumpectomy and radiation therapy versus mastectomy.

Authors:  E Obedian; D B Fischer; B G Haffty
Journal:  J Clin Oncol       Date:  2000-06       Impact factor: 44.544

Review 3.  Epidemiology of contralateral breast cancer.

Authors:  Y Chen; W Thompson; R Semenciw; Y Mao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-10       Impact factor: 4.254

4.  Second cancers after conservative surgery and radiation for stages I-II breast cancer: identifying a subset of women at increased risk.

Authors:  B Fowble; A Hanlon; G Freedman; N Nicolaou; P Anderson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-11-01       Impact factor: 7.038

5.  Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status.

Authors:  Bruce G Haffty; Elizabeth Harrold; Atif J Khan; Pradip Pathare; Tanya E Smith; Bruce C Turner; Peter M Glazer; Barbara Ward; Daryl Carter; Ellen Matloff; Allen E Bale; Mayra Alvarez-Franco
Journal:  Lancet       Date:  2002-04-27       Impact factor: 79.321

Review 6.  Radiation and breast carcinogenesis.

Authors:  J D Boice
Journal:  Med Pediatr Oncol       Date:  2001-05

7.  Radiation effects on breast cancer risk: a pooled analysis of eight cohorts.

Authors:  Dale L Preston; Anders Mattsson; Erik Holmberg; Roy Shore; Nancy G Hildreth; John D Boice
Journal:  Radiat Res       Date:  2002-08       Impact factor: 2.841

8.  Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease.

Authors:  Lois B Travis; Deirdre A Hill; Graça M Dores; Mary Gospodarowicz; Flora E van Leeuwen; Eric Holowaty; Bengt Glimelius; Michael Andersson; Tom Wiklund; Charles F Lynch; Mars B Van't Veer; Ingrid Glimelius; Hans Storm; Eero Pukkala; Marilyn Stovall; Rochelle Curtis; John D Boice; Ethel Gilbert
Journal:  JAMA       Date:  2003-07-23       Impact factor: 56.272

9.  Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study.

Authors:  Xiang Gao; Susan G Fisher; Bahman Emami
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-07-15       Impact factor: 7.038

10.  Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1990.

Authors:  Charles E Land; Masayoshi Tokunaga; Kojiro Koyama; Midori Soda; Dale L Preston; Issei Nishimori; Shoji Tokuoka
Journal:  Radiat Res       Date:  2003-12       Impact factor: 2.841

View more
  118 in total

Review 1.  Second malignant neoplasms and cardiovascular disease following radiotherapy.

Authors:  Lois B Travis; Andrea K Ng; James M Allan; Ching-Hon Pui; Ann R Kennedy; X George Xu; James A Purdy; Kimberly Applegate; Joachim Yahalom; Louis S Constine; Ethel S Gilbert; John D Boice
Journal:  J Natl Cancer Inst       Date:  2012-02-06       Impact factor: 13.506

2.  Segmented photon beams technique for irradiation of postmastectomy patients.

Authors:  Anna Semaniak; Zbigniew Jodkiewicz; Anna Skowrońska-Gardas
Journal:  Rep Pract Oncol Radiother       Date:  2012-03-08

3.  Safety and benefit of using a virtual bolus during treatment planning for breast cancer treated with arc therapy.

Authors:  Marguerite Tyran; Agnes Tallet; Michel Resbeut; Marjorie Ferre; Veronique Favrel; Pierre Fau; Laurence Moureau-Zabotto; Julien Darreon; Laurence Gonzague; Ahcene Benkemouche; Leonel Varela-Cagetti; Naji Salem; Bertrand Farnault; Marie-Aimee Acquaviva; Hugues Mailleux
Journal:  J Appl Clin Med Phys       Date:  2018-06-30       Impact factor: 2.102

4.  Variation in the risk of radiation-related contralateral breast cancer by histology and estrogen receptor expression in SEER.

Authors:  Gila Neta; William F Anderson; Ethel Gilbert; Amy Berrington
Journal:  Breast Cancer Res Treat       Date:  2011-10-21       Impact factor: 4.872

Review 5.  Secondary malignancies across the age spectrum.

Authors:  Andrea K Ng; Lisa B Kenney; Ethel S Gilbert; Lois B Travis
Journal:  Semin Radiat Oncol       Date:  2010-01       Impact factor: 5.934

Review 6.  New biological insights on the link between radiation exposure and breast cancer risk.

Authors:  Mary Helen Barcellos-Hoff
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-01-17       Impact factor: 2.673

7.  Hybrid volumetric modulated arc therapy for whole breast irradiation: a dosimetric comparison of different arc designs.

Authors:  Velayudham Ramasubramanian; Karunakaran Balaji; Sitaraman Balaji Subramanian; Krishnamoorthi Sathiya; Moorthi Thirunavukarasu; Chandrasekaran Anu Radha
Journal:  Radiol Med       Date:  2019-01-30       Impact factor: 3.469

Review 8.  Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors.

Authors:  Lois B Travis; Wendy Demark Wahnefried; James M Allan; Marie E Wood; Andrea K Ng
Journal:  Nat Rev Clin Oncol       Date:  2013-03-26       Impact factor: 66.675

9.  Node-positive left-sided breast cancer: does VMAT improve treatment plan quality with respect to IMRT?

Authors:  M Pasler; D Georg; S Bartelt; J Lutterbach
Journal:  Strahlenther Onkol       Date:  2013-03-24       Impact factor: 3.621

10.  Alcohol intake and cigarette smoking and risk of a contralateral breast cancer: The Women's Environmental Cancer and Radiation Epidemiology Study.

Authors:  Julia A Knight; Leslie Bernstein; Joan Largent; Marinela Capanu; Colin B Begg; Lene Mellemkjaer; Charles F Lynch; Kathleen E Malone; Anne S Reiner; Xiaolin Liang; Robert W Haile; John D Boice; Jonine L Bernstein
Journal:  Am J Epidemiol       Date:  2009-02-11       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.